Atalay, FigenKizilkilic, EbruAda, R. Simin2024-07-122024-07-1220131300-777710.4274/Tjh.2012.01472-s2.0-84879140260https://dx.doi.org/10.4274/Tjh.2012.0147https://hdl.handle.net/20.500.12415/8721eninfo:eu-repo/semantics/openAccessChronic Myelogenous LeukemiaImatinibPsoriasisImatinib-Induced PsoriasisLetter218224385791Q321630WOS:000320972500022Q4